Pioneer Fil-Med IPO Details

MAINBOARD NSE BSE

Pioneer Fil-Med IPO Summary

Pioneer Fil-Med Logo | Pioneer Fil-Med IPO Details, Date, Price, GMP, Live Subscription

Pioneer Fil-Med IPO DRHP (Draft Red Herring Prospectus) has been Filed With SEBI.

Pioneer Fil-Med IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.

The Lead Managers for Pioneer Fil-Med IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Equirus Capital Pvt Ltd, Nuvama Wealth Management Ltd . To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Pioneer Fil-Med Limited DRHP.

Pioneer Fil-Med IPO Details

Open Date
-
Close Date
-
Listing Date
-
Issue Price
₹0 - ₹0
Face Value
₹10 per share
Lot Size
Shares
GMP
₹0
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Pre-issue Shareholding
2,55,33,600 shares
Post-issue Shareholding
-
Total Issue Size
-
Fresh Issue
-
Offer for Sale
-
DRHP Status
Filed With SEBI

Pioneer Fil-Med IPO Lot Size

ApplicationLotsSharesAmount
To be announced

Pioneer Fil-Med IPO Reservation

Promoter Holding

Pre Issue:
95%
Post Issue:
-
Promoter Names:
Pioneer Facor IT Infradevelopers Private Limited, Pioneer Procon Private Limited, Pioneer Securities Private Limited, Pioneer Fincap Private Limited

Pioneer Fil-Med IPO Valuations

ROE13.34%
ROCE28.79%
Debt/Equity0.10
RoNW13.94%
PAT Margin12.39%
EBITDA Margin21.53%
EPS(₹) (Pre IPO)15.84

Pioneer Fil-Med Financial Information

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets296.15225.49181.19151.88
Total Income159.74331.13235.6190.38
Profit After Tax25.4140.4426.3911.17
EBITDA6.7839.5557.5133.61
NET Worth159.52137.28100.2977.36
Total Borrowing18.8718.558.5121.80
Amount in ₹ Crore

About Pioneer Fil-Med IPO

Pioneer Fil-Med Limited, incorporated in 1997, is engaged in the manufacturing and supply of railway and metro equipment, along with allied components for locomotive and coach applications in India. The company caters to both diesel-electric and electric platforms, supporting the evolving needs of the rail transportation sector.

Initially focused on manufacturing filters for railway and automotive applications, the company has progressively expanded its product portfolio to include traction motors, traction alternators, brake discs, gangways, stators, rotors, and platform screen doors, enabling it to offer a diversified range of critical components.

Pioneer Fil-Med Limited is an approved supplier to Indian Railways and is recognized among the Category-I approved suppliers for traction alternators. It also holds Category-I approvals for multiple products, including traction motors, HHP 4500 traction motors, brake discs, and filters, reflecting its strong technical capabilities and compliance with stringent industry standards.

The company has also diversified into the renewable energy segment through the supply of wind generators, expanding its presence beyond the railways sector.

Pioneer Fil-Med Limited operates three manufacturing facilities, with two located in Bawal, Haryana and one in Manesar, Haryana, supporting its production and supply capabilities.

As of December 31, 2025, the company had a workforce of 141 employees, contributing to its operations and growth initiatives.

The company is actively developing new products, including axle boxes, gangways for EMU and Vande Bharat coaches, gear cases, pistons, IGBT-based propulsion systems, and wheel-mounted discs, while focusing on strengthening long-term relationships with OEMs and expanding its footprint in both the railway and renewable energy sectors.

Strength Of Pioneer Fil-Med IPO

To be announced

Risk Of Pioneer Fil-Med IPO

To be announced

Objectives Pioneer Fil-Med IPO

1. Part financing the cost of establishing a gear box manufacturing facility at Salarpur, Bhiwadi, Rajasthan, India (“Gear Box Facility”);

2. Part financing the cost of establishing a wind generator components manufacturing facility at Salarpur, Bhiwadi, Rajasthan, India (“Wind Generator Components Manufacturing Facility”);

3. General corporate purposes

4. Total

Company Contact Details

502 Padma Palace 86 Nehru Place
New Delhi, New Delhi , 110019
Phone: 011-4563 8314
Email: cs@pioneerfilmed.com
Website: https://pioneerfilmed.com/

Registrar Contact Details

Name:
MUFG Intime India Pvt Ltd
Phone:
+91-22-4918 6270

Pioneer Fil-Med FAQs

The Pioneer Fil-Med IPO is a MAINBOARD public issue comprising equity shares with a face value of ₹10 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is shares.

The IPO opens for subscription on TBA, and closes on TBA.

MUFG Intime India Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

The Pioneer Fil-Med IPO opens on TBA.

Pioneer Fil-Med IPO lot size is , and the minimum amount required for application is ₹.

You may apply for the Pioneer Fil-Med IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Pioneer Fil-Med IPO is scheduled to be finalized on TBA. Subsequently, the shares allotted will be credited to investors’ demat accounts by TBA. Investors are advised to regularly check the Pioneer Fil-Med IPO allotment status for updates.

The listing date for the Pioneer Fil-Med IPO has not yet been officially announced. However, the tentative listing date is scheduled for TBA.

Pioneer Fil-Med IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at TBA.

Comments

Download A2ZIPO App for Live IPO Subscription and GMPA2ZIPO - Get Latest Mainboard and SME IPO Details